Ascletis Pharmaceuticals Articles

Third deal for Ascletis, which gains China market rights from Janssen to a clinical stage HIV protease inhibitor

1 May 2013

Roche teams up with Ascletis on hep C treatments for China

15 April 2013

Alnylam and Ascletis collaborate to develop ALN-VSP for liver cancers in China

15 July 2012

USA and China-based Ascletis raises $100 million for specialty therapeutics venture

7 April 2011

Showing 1-4 of 4 articles

Go to beginningPrevious
  • 1
NextGo to end